Ellington Jeffrey MD is categorized under Internal Medicine Doctors in Gulf Breeze, FL and active since 2007.
Ellington Jeffrey MD was established in 2007, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Ellington at the company’s single location by writing to 8880 Navarre Parkway # 101, Gulf Breeze, Florida FL 32566 or by phoning (850) 936-6211. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ellington Jeffrey MD |
| Contact Person: | Jeffrey Ellington |
| Address: | 8880 Navarre Parkway # 101, Gulf Breeze, Florida 32566 |
| Phone Number: | (850) 936-6211 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Ellington Jeffrey MD was started in 2007 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Jeffrey Ellington for inquiries that concern Ellington Jeffrey MD by calling the company number (850) 936-6211, as your correspondence is most welcome. Additionally, the physical location of the single location of Ellington Jeffrey MD can be found at the coordinates 30.4055,-86.85066 as well as the street address 8880 Navarre Parkway # 101 in Gulf Breeze, Florida 32566.
For its online presence, you may visit Ellington Jeffrey MD’s website at and engage with its social media outlets through on Twitter and on Facebook.